IQVIA's second quarter results beat estimates on strong R&D bookings, prompting a full-year 2026 guidance raise.

IQVIA reported second quarter 2026 revenue of $4.37 billion and adjusted EPS of $3.15, beating analyst estimates of $4.31 billion and $3.02, respectively. The results were driven by broad-based strength, particularly record bookings in the Research & Development segment.

Key Highlights

• R&D Solutions net new bookings reached a record $3.15 billion, an increase of 19% year-over-year, resulting in a strong book-to-bill ratio of 1.22x.
• The company raised its full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted Diluted EPS, citing stronger organic growth momentum.
• The Research & Development Solutions contracted backlog stood at $34.2 billion at the end of the quarter, with approximately $9.2 billion expected to convert to revenue in the next twelve months.
• Both major segments delivered strong growth, with R&D Solutions revenue up 8.8% and Commercial Solutions revenue up 8.6% year-over-year.